Accelerate Diagnostics (AXDX) Short Interest Ratio & Short Volume → My top 100 stocks… (From DTI) (Ad) Free AXDX Stock Alerts $0.93 -0.02 (-2.11%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Accelerate Diagnostics Short Interest DataCurrent Short Volume373,700 sharesPrevious Short Volume292,600 sharesChange Vs. Previous Month+27.72%Dollar Volume Sold Short$326,987.50Short Interest Ratio / Days to Cover4.3Last Record DateApril 15, 2024Outstanding Shares21,660,000 sharesFloat Size12,870,000 sharesShort Percent of Float2.90%Today's Trading Volume4,924 sharesAverage Trading Volume68,499 sharesToday's Volume Vs. Average7% Short Selling Accelerate Diagnostics ? Sign up to receive the latest short interest report for Accelerate Diagnostics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAXDX Short Interest Over TimeAXDX Days to Cover Over TimeAXDX Percentage of Float Shorted Over Time Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details Accelerate Diagnostics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024373,700 shares $326,987.50 +27.7%2.9%4.3 $0.88 3/31/2024292,600 shares $289,674.00 +1.7%2.3%2.2 $0.99 3/15/2024287,600 shares $273,220.00 -3.8%2.4%2.4 $0.95 2/29/2024299,000 shares $294,544.90 -13.9%2.5%2.5 $0.99 2/15/2024347,300 shares $413,287.00 -7.2%2.9%3 $1.19 1/31/2024374,200 shares $497,686.00 -16.5%4.2%3.4 $1.33 Get the Latest News and Ratings for AXDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Accelerate Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024448,300 shares $1.66 million +9.9%5.8%5.3 $3.70 12/31/2023407,800 shares $1.60 million +3.6%5.3%14.1 $3.92 12/15/2023393,500 shares $1.81 million -10.0%5.1%13.9 $4.61 11/30/2023437,300 shares $1.89 million +11.9%5.8%17.6 $4.32 11/15/2023390,900 shares $2.07 million -2.4%5.2%23.1 $5.29 10/31/2023400,500 shares $2.40 million +11.8%5.4%23 $5.99 10/15/2023358,100 shares $2.11 million +11.5%4.8%17.9 $5.88 9/30/2023321,300 shares $1.85 million -8.9%4.3%13 $5.75 9/15/2023352,600 shares $2.16 million -15.2%4.7%15.3 $6.14 8/31/2023415,800 shares $2.91 million -1.2%9.3%15.6 $7.01 8/15/2023420,900 shares $2.98 million -3.8%9.4%15.1 $7.09 7/31/2023437,400 shares $2.91 million +8.4%14.1%15.9 $6.66 7/15/2023403,500 shares $2.80 million +3.5%13.0%14.6 $6.95 6/30/2023390,000 shares $3.16 million -90.3%12.5%16.3 $8.10 6/15/20234,000,000 shares $3.17 million -7.6%12.9%14.9 $0.79 5/31/20234,330,000 shares $3.03 million +6.7%N/A16.7 $0.70 5/15/20234,060,000 shares $3.25 million -6.0%N/A13.4 $0.80 4/30/20234,320,000 shares $3.81 million -11.1%N/A14 $0.88 4/15/20234,860,000 shares $3.21 million +2.1%N/A16 $0.66 3/31/20234,760,000 shares $3.33 million -6.1%N/A16.2 $0.70 3/15/20235,070,000 shares $2.74 million +7.2%N/A16.6 $0.54 2/28/20234,730,000 shares $2.41 million +5.1%N/A15 $0.51 2/15/20234,500,000 shares $2.70 million +0.5%N/A15.5 $0.60 1/31/20234,480,000 shares $3.11 million +0.5%N/A15.8 $0.69 1/15/20234,460,000 shares $3.21 million -0.7%N/A13.3 $0.72 12/30/20224,490,000 shares $3.17 million +3.7%N/A13.6 $0.71 12/15/20224,330,000 shares $2.94 million -0.2%N/A14.6 $0.68 11/30/20224,340,000 shares $3.77 million +10.7%N/A12.8 $0.87 11/15/20223,920,000 shares $4.78 million -1.3%N/A8.4 $1.22 10/31/20223,970,000 shares $5.04 million -17.6%N/A4.3 $1.27 10/15/20224,820,000 shares $7.42 million -1.8%N/A5.1 $1.54 9/30/20224,910,000 shares $7.46 million -3.0%N/A5.3 $1.52 9/15/20225,060,000 shares $8.30 million -1.8%N/A4.6 $1.64 8/31/20225,150,000 shares $8.39 million -8.9%N/A4.1 $1.63Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details AXDX Short Interest - Frequently Asked Questions What is Accelerate Diagnostics' current short interest? Short interest is the volume of Accelerate Diagnostics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 373,700 shares of AXDX short. 2.90% of Accelerate Diagnostics' shares are currently sold short. Learn More on Accelerate Diagnostics' current short interest. What is a good short interest ratio for Accelerate Diagnostics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AXDX shares currently have a short interest ratio of 4.0. Learn More on Accelerate Diagnostics's short interest ratio. Which institutional investors are shorting Accelerate Diagnostics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Accelerate Diagnostics: Concourse Financial Group Securities Inc., and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Accelerate Diagnostics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.90% of Accelerate Diagnostics' floating shares are currently sold short. Is Accelerate Diagnostics' short interest increasing or decreasing? Accelerate Diagnostics saw a increase in short interest in April. As of April 15th, there was short interest totaling 373,700 shares, an increase of 27.7% from the previous total of 292,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Accelerate Diagnostics' float size? Accelerate Diagnostics currently has issued a total of 21,660,000 shares. Some of Accelerate Diagnostics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Accelerate Diagnostics currently has a public float of 12,870,000 shares. How does Accelerate Diagnostics' short interest compare to its competitors? 2.90% of Accelerate Diagnostics' shares are currently sold short. Here is how the short interest of companies compare to Accelerate Diagnostics: Cue Health Inc. (0.52%), Talis Biomedical Co. (0.74%), Singular Genomics Systems, Inc. (1.42%), Telesis Bio, Inc. (1.20%), Precipio, Inc. (0.41%), Rapid Micro Biosystems, Inc. (0.33%), Bionano Genomics, Inc. (8.85%), Ekso Bionics Holdings, Inc. (1.06%), Vincerx Pharma, Inc. (8.91%), GlucoTrack, Inc. (0.51%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Accelerate Diagnostics stock? Short selling AXDX is an investing strategy that aims to generate trading profit from Accelerate Diagnostics as its price is falling. AXDX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Accelerate Diagnostics? A short squeeze for Accelerate Diagnostics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AXDX, which in turn drives the price of the stock up even further. How often is Accelerate Diagnostics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AXDX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Cue Health Short Interest Data Talis Biomedical Short Interest Data Singular Genomics Systems Short Interest Data Telesis Bio Short Interest Data Precipio Short Interest Data Rapid Micro Biosystems Short Interest Data Bionano Genomics Short Interest Data Ekso Bionics Short Interest Data Vincerx Pharma Short Interest Data GlucoTrack Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AXDX) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe only accurate crypto trading system I know …Weiss Ratings